Angiopoietin-1 Suppresses Choroidal Neovascularization and Vascular Leakage

Abstract

Ang1 supplementation can be established as a therapeutic strategy to suppress the CNV formation and vascular leakage by inhibiting the recruitment of angiogenic macrophages and tightening the endothelial junctions.